BioMarin Pharmaceutical Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for BioMarin Pharmaceutical Inc. (BMRN) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Operating Activities
Net Income426.86167.65141.56-64.08854.03-23.85-77.21
Depreciation & Amortization96.43104.39101.97117.34105.17117.2695.67
Deferred Income Tax56.10-44.98-52.09-15.61-888.91-82.76-68.38
Stock Based Compensation201.57207.10196.31197.26189.710.000.00
Change in Working Capital-216.40-336.54-96.3866.03-224.94-101.09-49.42
Change in Accounts Receivable-57.91-190.44-82.0365.57-59.040.000.00
Change in Inventory-63.53-157.06-68.26-35.06-61.150.000.00
Change in Accounts Payable-32.2468.8559.0215.69-87.030.000.00
Change in Other Working Capital-62.723.823.7819.83-17.720.000.00
Other Operating Activities62.843.823.78194.63-786.36157.4738.14
Net Cash from Operating Activities572.84159.26175.90304.5485.3743.0620.21
Investing Activities
Capital Expenditures-85.42-107.61-131.54119.23-114.31163.41-144.62
Acquisitions0.000.001.708.034.505.210.00
Purchases of Investments222.77-868.50-611.81-246.0926.170.000.00
Sales/Maturities of Investments-1.99864.86620.00-247.0943.95132.38358.98
Other Investing Activities1.140.00103.33-0.99-9.4324.1949.99
Net Cash from Investing Activities136.49-111.24-20.03-366.31-53.62-25.82264.35
Financing Activities
Debt Repayment-494.990.00-2.61-3.04-381.910.00-374.95
Common Stock Issued49.2869.3569.3349.1971.910.000.00
Common Stock Repurchased-77.56-76.32-54.28-45.81-94.640.000.00
Other Financing Activities-3.18-88.08-87.98-46.20-44.64-106.29-80.54
Net Cash from Financing Activities-526.45-18.73-18.65-0.05181.12-74.67-388.01
Summary
Effect of Forex Changes on Cash4.831.310.03-0.06-1.150.90-0.60
Net Change in Cash187.7229.29137.22-61.83211.71-57.44-103.45
Cash at Beginning of Period755.13724.53587.28649.16437.45493.98598.03
Cash at End of Period942.84755.13724.53587.28649.16437.45493.98
Free Cash Flow487.4251.6544.36185.31-28.95-120.35-124.41
Supplemental Disclosures
Interest Paid10.3610.3010.2810.4012.188.5511.62
Income Taxes Paid57.2773.3154.3718.158.989.7316.68